Modelling breast cancer: one size does not fit all
- PMID: 17721431
- DOI: 10.1038/nrc2193
Modelling breast cancer: one size does not fit all
Abstract
Breast cancer is not a single disease, but is instead a collection of diseases that have distinct histopathological features, genetic and genomic variability, and diverse prognostic outcomes. Thus, no individual model would be expected to completely recapitulate this complex disease. Here, the models commonly used to investigate breast cancer including cell lines, xenografts and genetically engineered mice, are discussed to help address the question: what is the most powerful way to investigate this heterogeneous disease?
Similar articles
-
Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis.Breast. 2013 Aug;22 Suppl 2:S57-65. doi: 10.1016/j.breast.2013.07.011. Breast. 2013. PMID: 24074794 Review.
-
Studying drug resistance using genetically engineered mouse models for breast cancer.Methods Mol Biol. 2010;596:33-45. doi: 10.1007/978-1-60761-416-6_3. Methods Mol Biol. 2010. PMID: 19949919
-
In vivo xenograft models of breast cancer metastasis.Methods Mol Med. 2006;120:479-88. doi: 10.1385/1-59259-969-9:479. Methods Mol Med. 2006. PMID: 16491620
-
Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review).Oncol Rep. 2011 May;25(5):1195-201. doi: 10.3892/or.2011.1215. Epub 2011 Mar 10. Oncol Rep. 2011. PMID: 21399881 Review.
-
An immunotolerant HER-2/neu transgenic mouse model of metastatic breast cancer.Clin Cancer Res. 2008 Oct 1;14(19):6116-24. doi: 10.1158/1078-0432.CCR-07-4672. Clin Cancer Res. 2008. PMID: 18829490 Free PMC article.
Cited by
-
LncRNA SNHG6 sponges miR-101 and induces tamoxifen resistance in breast cancer cells through induction of EMT.Front Oncol. 2022 Sep 23;12:1015428. doi: 10.3389/fonc.2022.1015428. eCollection 2022. Front Oncol. 2022. PMID: 36212408 Free PMC article.
-
The Action of Discoidin Domain Receptor 2 in Basal Tumor Cells and Stromal Cancer-Associated Fibroblasts Is Critical for Breast Cancer Metastasis.Cell Rep. 2016 Jun 14;15(11):2510-23. doi: 10.1016/j.celrep.2016.05.033. Epub 2016 Jun 2. Cell Rep. 2016. PMID: 27264173 Free PMC article.
-
ST09, A Novel Curcumin Derivative, Blocks Cell Migration by Inhibiting Matrix Metalloproteases in Breast Cancer Cells and Inhibits Tumor Progression in EAC Mouse Tumor Models.Molecules. 2020 Sep 30;25(19):4499. doi: 10.3390/molecules25194499. Molecules. 2020. PMID: 33008036 Free PMC article.
-
A living biobank of canine mammary tumor organoids as a comparative model for human breast cancer.Sci Rep. 2022 Oct 27;12(1):18051. doi: 10.1038/s41598-022-21706-2. Sci Rep. 2022. PMID: 36302863 Free PMC article.
-
G Protein-coupled Receptor Kinase 2 (GRK2) Promotes Breast Tumorigenesis Through a HDAC6-Pin1 Axis.EBioMedicine. 2016 Nov;13:132-145. doi: 10.1016/j.ebiom.2016.09.030. Epub 2016 Oct 1. EBioMedicine. 2016. PMID: 27720394 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
